Julija Čiauškaitė 1,*, Ieva Puleikytė1, Simonas Jesmanas 2, Giedrė Jurkevičienė 1, Antanas Vaitkus 1and Daiva Rastenytė 1
1 Department of Neurology, Medical Academy, Lithuanian University of Health Sciences;
2 Department of Radiology, Medical Academy, Lithuanian University of Health Sciences;
* Correspondence: juliciau0522@kmu.lt.
Key Clinical Message: Neuroleptic malignant syndrome associated with quetiapine in a patient with Creutzfeldt-Jakob disease.
Abstract: Creutzfeldt – Jakob disease (CJD) is a rare neurodegenerative disease with complex clinical manifestations. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which are used to treat neuropsychiatric symptoms of CJD. We present a case of a 51-year-old woman with CJD who developed NMS after being prescribed quetiapine.
Keywords: Creutzfeldt-Jakob disease; neuroleptic malignant syndrome; magnetic resonance imaging; electroencephalography.